Beijing Kawin Technology Share-Holding Company Description

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China.

The company’s products include recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon Alfacon-2 Injection; and compound glycyrrhizin tablets, capsules, and injections, as well as pirfenidone tablets.

The company was founded in 2008 and is based in Beijing, China.

Beijing Kawin Technology Share-Holding Co., Ltd.

Country	China
Founded	2008
Industry	Biotechnology
Sector	Healthcare
Employees	584
CEO	Desheng Zhou

Contact Details

Address: Building 3, No. 6, Rongjing East Street Beijing, 100176 China
Phone	86 10 6789 2271
Website	kawin.com.cn

Stock Details

Ticker Symbol	688687
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000054C3
SIC Code	2836

Key Executives

Name	Position
Dongxia Li	Vice President of Beiyi Protein